Company intelligence / Profile preview
BERG
Framingham, Massachusetts, United Statesprnewswire.com ↗
- Ownership
- Private
- Employees
- ~77
- Development stage
- Phase 2
01
Overview
Initial results from a Phase II trial of BPM31510 in pancreatic cancer showed preliminary efficacy in patients refractory to standard chemotherapy. The company has identified potential biomarkers predictive of response using its AI platform. Other assets have shown safety/tolerability signals or are advancing through preclinical stages.
- Therapeutic areas
- OncologyNeurology
- Modalities
- Small molecules (e.g., BPM31510: ubidecarenone)Topical agents (e.g., BPM31543: calcitriol)Diagnostics (biomarker-driven approaches)
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Request access →03
Partnerships
Academic collaborations with Harvard University and the Pancreatic Cancer Research Center for biomarker discovery/validation.Collaborations with Stanford Medicine on glioblastoma trials.
Beyond the preview
Go deeper on BERG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BERG.